Dr Paul Briley is Clinical Associate Professor in Mood Disorders at the University of Nottingham. He has a BMBS in Medicine, a BSc in Mathematics and Statistics, and a BSc and PhD in Psychology.

Paul is also Clinical Lead for the Nottinghamshire Research and Advice in Depression (NRAD) clinics, which provide assessments, next steps treatment advice, and access to research opportunities for patients from partnering GP practices in underserved communities.

Paul worked on the BRIGhTMIND trial of transcranial magnetic stimulation (TMS) for treating depression. TMS is a non-invasive "neuromodulation" (non-invasive brain stimulation) treatment. It uses magnetic pulses to rebalance brain networks across multiple treatment sessions. It is non-invasive and safe, and patients can chat to clinic staff during treatment and go home straight after.

Paul studies ways to boost response to TMS - to help more patients obtain more benefit more quickly - as well as ways to make treatment more accessible. He has obtained a new four-year NIHR Fellowship that will identify promising approaches to boost response to TMS and increase accessibility, working with people with lived experience of depression as well as clinicians, commissioners and industry. It will then run a feasibility clinical trial of the most promising approaches.

Paul is particularly interested in patient and public involvement in research, and is on the steering committee for the NIHR HealthTech Research Centre Mental Health (MindTech) Lived Experience Access to Research Network.

View Paul's Orcid page